Abbott broadens EU marketing for cancer Dx; Boston hospital concocts quick release surgical tape;

 @FierceMedDev: Ariste Medical raised $1.275M in seed money to advance development of a drug-coated vascular graft. More | Follow @FierceMedDev

 @MarkHFierce: CryoLife celebrates 13% revenue jump in Q3. More | Follow @MarkHFierce

 @DamianFierce: Orthofix pays $32M to settle allegations it gave kickbacks--including parties with strippers & prostitutes--to docs. More | Follow @DamianFierce

> Abbott ($ABT) says it will expand the current product labeling for a non-small cell lung cancer test so it can be marketed in the European Union as a companion diagnostic. Item

> Parker Hannifin ($PH) will license exoskeleton device technology from Vanderbilt University and hopes to launch it commercially in 2014. Item

> Ariste Medical raised $1.275 million in seed money toward development of a drug-eluting vascular graft designed to prevent graft failure in hemodialysis patients. Item

> Tryton Medical presented robust data regarding 905 patients whose bifurcation lesions were treated with the company's side branch stent. Item

> Smiths Medical in Minnesota gained a CE mark for a new safety IV catheter for intravenous infusion. Release

> Brigham and Women's Hospital researchers came up with a quick-release surgical tape that sticks but is easy to remove--a crucial advance for neonatal patients in particular. Release

Biotech News

 @FierceBiotech: Alzheimers investigators see fresh sign of solanezumab success in $LLY study. More | Follow @FierceBiotech

 @JohnCFierce: Biotech companies out there. You have any bad news to report? Do it now. Take advantage of the perfect storm to confess your sins quietly. | Follow @JohnCFierce

 @RyanMFierce: Focusing on hoped-for launch of tivozanib, $AVEO is axing 45 jobs or 17% of workers, eliminating 30 openings. More | Follow @RyanMFierce

> Cigarette maker Philip Morris rolls vaccine interests into China. Story

> Financial woes reduce AstraZeneca's industry profile. Item

> Theratechnologies once again tries to slash its way to breakeven point. Article

Pharma News

@FiercePharma: Korean pharma stocks are riding an updraft of M&A speculation. Keunwha, Hondok way up ... anyone shopping? More | Follow @FiercePharma

> Boehringer Ingelheim bets bigger on respiratory drugs. Story

> Bayer adds vitamin maker Schiff to buyout tally with $1.2B deal. News

> Patheon nabs Mexican beachhead with $255M Banner buyout. Report

Pharma Manufacturing News

> Boehringer again doubling capacity at inhaler plant. Report

> Patheon will pick up four plants with Banner buyout. News

> Congressional report calls for FDA to regulate large compounders. Article

> Drugmakers close plants ahead in face of Hurricane Sandy. Item

Biotech Research News

> Wisconsin company to provide stem cells for NIH research. Story

> Roche drug, microRNA treatment conquered head and neck cancer cells. News

> Baker's yeast yields possible Lou Gehrig's disease drug target. Article

> Duke team builds viable cartilage from induced pluripotent stem cells. Report

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.